News
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and ...
MedPage Today on MSN3d
Did FDA Pick the Wrong COVID Vaccine Strain Last Season?
A separate Danish study showed that the two mRNA vaccines were also safe, with no increase in adverse events of special ...
Dr. Vinay Prasad, an oncologist who was a fierce critic of COVID vaccine and mask mandates, was appointed in May.
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...
The U.S. Food and Drug Administration's top official, Vinay Prasad, has left the agency after nearly three months as Director ...
DIRECTING A CHANGING CDC — The Senate voted to confirm Susan Monarez as the next CDC director Tuesday, marking an end to the ...
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure.
The FDA's top vaccine official is stepping down after just 3 months in a role that upset drug companies, patient groups and some political leaders.
Novavax on Wednesday raised its full-year revenue forecast as it received a $175 million milestone payment from Sanofi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback